Role of cysteinyl leukotriene receptor-1 antagonists in treatment of experimentally induced mammary tumor

Renal Cell Carcinoma Tumors Induce T Cell Apoptosis through Receptor-Dependent and Receptor-Independent Pathways

(2014) T. Das et al.   JOURNAL OF IMMUNOLOGY

Tumor-associated neutrophils: friend or foe?

(2012) Z. G. Fridlender et al.   CARCINOGENESIS

Antitumor properties of Boswellic acid against Ehrlich ascites cells bearing mouse

(2011) S.S. Agrawal et al.   FOOD AND CHEMICAL TOXICOLOGY

Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts

(2010) Sankar Bhattacharyya et al.   Cellular & Molecular Immunology

NF-ĸB and Bcl-3 Activation Are Prognostic in Metastatic Colorectal Cancer

(2010) Soham D. Puvvada et al.   ONCOLOGY

Inflammation and cancer: how friendly is the relationship for cancer patients?

(2009) Bharat B Aggarwal et al.   CURRENT OPINION IN PHARMACOLOGY

Relationship Between Cysteinyl-Leukotriene-1 Receptor and Human Transitional Cell Carcinoma in Bladder

(2009) Masahide Matsuyama et al.   UROLOGY

A polyherbal ayurvedic drug – Indukantha Ghritha as an adjuvant to cancer chemotherapy via immunomodulation

(2008) S GEORGE et al.   IMMUNOBIOLOGY

Antineoplasic activity of Copaifera multijuga oil and fractions against ascitic and solid Ehrlich tumor

(2008) Niele de Matos Gomes et al.   JOURNAL OF ETHNOPHARMACOLOGY

Inhibition of p38 MAPK Suppresses Inflammatory Cytokine Induction by Etoposide, 5-Fluorouracil, and Doxorubicin without Affecting Tumoricidal Activity

(2008) Collin R. Elsea et al.   PLoS One